ZVSA insider transaction filings
ZyVersa Therapeutics, Inc. — 15 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-07-16. Screen ZVSA transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ZVSA between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — ZyVersa Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-16 | 4 | Cashmere Karen A. — Chief Commercial Officer | Grant/award (A): 48,100 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | Wolfe Peter — Chief Financial Officer | Grant/award (A): 60,100 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | Park Min-Chul — Director | Grant/award (A): 11,066 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | Guzman Pablo A. — Chief Medical Officer | Grant/award (A): 48,900 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | SAPIRSTEIN JAMES — Director | Grant/award (A): 11,066 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | Finizio Robert G — Director | Grant/award (A): 11,066 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | Freitag Gregory Gene — Director | Grant/award (A): 11,066 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | Glover Stephen C. — Chief Executive Officer, Director | Grant/award (A): 136,900 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | Wolfe Peter — Chief Financial Officer | Grant/award (A): 715 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | Park Min-Chul — Director | Grant/award (A): 132 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | Cashmere Karen A. — Director | Grant/award (A): 572 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | SAPIRSTEIN JAMES — Director | Grant/award (A): 132 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | Finizio Robert G — Director | Grant/award (A): 132 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | Freitag Gregory Gene — Director | Grant/award (A): 132 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | Glover Stephen C. — Chief Executive Officer, Director | Grant/award (A): 1,627 (derivative) @ $0 | EDGAR |
Recent 8-K events — ZyVersa Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2026-03-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-09-18 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-07-28 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-16 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ZVSA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →